LX Bio Pharmaceuticals

Lxbio Pharmaceuticals operates in the biotechnology sector with a primary focus on phage therapy, aiming to develop solutions that transform disease treatment and prevention. The company targets a global market, striving to improve the quality of life sustainably. Lxbio's business model involves research and development projects supported by significant investments, such as the recent 6 million Euros from Explorer Investments. This funding aids in expanding their high-value product exports and promoting skilled employment in Portugal. Lxbio is committed to ethical and responsible biotechnological advancements, aspiring to inspire a new era in healthcare. The company ensures data protection and privacy, retaining user information only as necessary for service provision. Keywords: biotechnology, phage therapy, disease treatment, prevention, global market, research, development, investment, ethical, healthcare.